<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal Of Health Sciences</title>
<title_fa>علوم بهداشتی ایران</title_fa>
<short_title>Iran J Health Sci</short_title>
<subject>Medical Sciences</subject>
<web_url>http://jhs.mazums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-553X</journal_id_issn>
<journal_id_issn_online>2981-2240</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/jhs</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1395</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2016</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<volume>4</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>fa</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Application of the Weibull Accelerated Failure Time Model in the Determination of Disease-Free Survival Rate of Patients with Breast Cancer</title>
	<subject_fa>آمار زیستی</subject_fa>
	<subject>Biostatistics</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;font size=&quot;4&quot;&gt;&lt;font size=&quot;4&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;Background and Purpose: &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;The goal of this study is application of the proportional hazards &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;model (PH) and accelerated failure time model (AFT), with consideration Weibull distribution, &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;to determine the level of effectiveness of the factors affecting on the level of disease-free &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;survival (DFS) of the patients with breast cancer.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;font size=&quot;4&quot;&gt;&lt;font size=&quot;4&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;Materials and Methods: &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;Based on the retrospective descriptive studies, 377 female patients with &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;primary breast cancer that had been treated at oncology section (Omid Hospital) in Mashhad, &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;Iran, were considered for participation in the study&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;font size=&quot;4&quot;&gt;&lt;font size=&quot;4&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;Results: &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;The median was 2 years and 10 months (mean 2 years and 4 months, interquartile range &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;3 years and 7 months, range 1-2920 days or 8 years). The average age of patients was &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;49.2 &amp;plusmn; 11.5 (range 25-80 years). The rate of DFS determined with 52.5%. Base on the result of &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;PHs Weibull model, the risk of the metastasis after surgery in the patients with invasive tumors &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;to the skin and chest and positive lymph node was more than 2 times [hazard ratio (HR) = 2.53; &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;confidence interval (CI): 1.26, 5.06] and (HR = 2.37 CI: 1.42, 3.98), respectively. Hormone &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;therapy after surgery decreases the risk of the metastasis to 0.63% (HR = 0.63; CI: 0.41, 0.95). In &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;the AFT model, characteristic tumor decelerated (&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt;&amp;gamma; &lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;&lt; 1) the DFS time by a factor of 0.30 and 0.33, &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;respectively. Furthermore, the hormonal therapy accelerated (&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;font face=&quot;Times New Roman&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&amp;gamma; &lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot;&gt;&lt;font size=&quot;3&quot;&gt;&gt; 1) the DFS time by factor of 1.8.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;4&quot;&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;4&quot;&gt;Conclusion: &lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt;In this study, the PH and AFT assumption have been satisfied by data and &lt;/font&gt;&lt;/font&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt;characteristics tumor and the hormonal therapy decrease and increases time until recurrence, &lt;/font&gt;&lt;/font&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt;respectively.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Disease-free Survival, Breast Neoplasms, Proportional Hazard, Parametric Model, Accelerated</keyword>
	<start_page>11</start_page>
	<end_page>18</end_page>
	<web_url>http://jhs.mazums.ac.ir/browse.php?a_code=A-10-60-2&amp;slc_lang=fa&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Narges </first_name>
	<middle_name></middle_name>
	<last_name>Ghorbani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846004651</code>
	<orcid>10031947532846004651</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Mazandaran University of medical sciences</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Jamshid </first_name>
	<middle_name></middle_name>
	<last_name>Yazdani-Charati</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>jamshid.charati@gmail.com</email>
	<code>10031947532846004652</code>
	<orcid>10031947532846004652</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Mazandaran University of medical sciences</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Kazem </first_name>
	<middle_name></middle_name>
	<last_name>Anvari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846004653</code>
	<orcid>10031947532846004653</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Mashhad University of Medical Sciences, Mashhad,</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Nasrin </first_name>
	<middle_name></middle_name>
	<last_name>Ghorbani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846004654</code>
	<orcid>10031947532846004654</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Mashhad University of Medical Sciences, Mashhad,</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
